All news

Conexeu Sciences closes $5 million insider-led placement

Alpha Vantage · The Manila Times · · AI-summarised by FinFlash

Conexeu Sciences Inc. (Nasdaq: CNXU) closed a $5 million private placement with significant participation from existing shareholders, management and directors. Proceeds will fund manufacturing scale-up, regulatory testing and preclinical work ahead of a planned FDA 510(k) submission in Q1 2027 for lead wound care device Ten Minute Tissue. Some management and director subscriptions sit in escrow pending stockholder approval.

Read original source

CNXU company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.